Cohort characteristics: anthropometric data, blood pressure, standard blood chemistry variables and 25(OH)D₃ levels.

Central obesity: waist-to-height ration >0.5 [31]; elevated BP: systolic BP (SBP)≥130 mm Hg and/or diastolic BP (DBP)≥85 mm Hg; increased atherogenic risk: AIP≥0.11 [29]; and insulin resistance: QUICKI<0.322 were considered as factors indicated increased cardiometabolic risk. 0: no risk factor presented (n = 162); 1–2: subjects with 1 or 2 risk factors (n = 162); 3–4: subjects presenting 3 or 4 risk factors (n = 87); F: females; M: males; BMI: body mass index; ICO: index of central obesity; SBP: systolic blood pressure; DBP: diastolic blood pressure; MAP: mean arterial pressure; PP: pulse pressure; FPG: fasting plasma glucose; FIns: fasting plasma insulin; QUICKI: quantitative insulin sensitivity check index; CHOL: total cholesterol; HDL-C: high density lipoprotein cholesterol; LDL-C: low density lipoprotein cholesterol; VLDL-C: very low density lipoprotein cholesterol; TAG: triacylglycerols; AIP: atherogenic index of plasma; eGFR: estimated glomerular filtration rate; Vitamin D3: plasma 25(OH)D3; PTH: intact parathormone; chi: chi-square *: p<0.05 vs. cardiometabolic risk factors free subjects **: p<0.01 vs. cardiometabolic risk factors free subjects ***: p<0.001 vs. cardiometabolic risk factors free subjects +: p<0.05 vs. subjects presenting 1 or 2 cardiometabolic risk factors ++: p<0.01 vs. subjects presenting 1 or 2 cardiometabolic risk factors +++: p<0.001 vs. subjects presenting 1 or 2 cardiometabolic risk factors; italics: statistical evaluation performed on logarithmically transformed data Cohort characteristics: anthropometric data, blood pressure, standard blood chemistry variables and 25(OH)D3 levels.